Vol 6, No 4 (2020)
Review paper
Published online: 2020-12-08
Get Citation

The new European League Against Rheumatism/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus

Izabela Machlarz1, Adam Reich1
·
Forum Dermatologicum 2020;6(4):108-112.
Affiliations
  1. Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University

paid access

Vol 6, No 4 (2020)
REVIEW ARTICLES
Published online: 2020-12-08

Abstract

The systemic lupus erythematosus (SLE) is an autoimmune disease which can affect almost all organs. The diagnosis of lupus is hindered by the multitude of similar clinical symptoms occurring at different time intervals, non-specific laboratory abnormalities and histopathological features that may also occur in other diseases. The presence of antibodies against self-antigens, especially antinuclear antibodies, is of great importance in the diagnostic process. Rapid diagnosis of the disease and implementation of appropriate treatment is crucial for therapeutic success and enables to prevent many complications. In 2018, new classification criteria for SLE were developed, namely EULAR/ACR 2019 criteria, which were based on the previous SLICC and ACR criteria but have been markedly modified. These criteria were divided into 7 clinical and 3 immunological domains. The preliminary criterion is at least a single confirmation of the presence of antinuclear antibodies with a titer of ≥ 1: 80, and next to achieving ≥ 10 points from pre-defined symptoms, including at least 1 criterion from the clinical domain. Only one symptom with the highest score from each domain is used for the total sum calculation.

Abstract

The systemic lupus erythematosus (SLE) is an autoimmune disease which can affect almost all organs. The diagnosis of lupus is hindered by the multitude of similar clinical symptoms occurring at different time intervals, non-specific laboratory abnormalities and histopathological features that may also occur in other diseases. The presence of antibodies against self-antigens, especially antinuclear antibodies, is of great importance in the diagnostic process. Rapid diagnosis of the disease and implementation of appropriate treatment is crucial for therapeutic success and enables to prevent many complications. In 2018, new classification criteria for SLE were developed, namely EULAR/ACR 2019 criteria, which were based on the previous SLICC and ACR criteria but have been markedly modified. These criteria were divided into 7 clinical and 3 immunological domains. The preliminary criterion is at least a single confirmation of the presence of antinuclear antibodies with a titer of ≥ 1: 80, and next to achieving ≥ 10 points from pre-defined symptoms, including at least 1 criterion from the clinical domain. Only one symptom with the highest score from each domain is used for the total sum calculation.

Get Citation

Keywords

diagnostics; criteria; diagnosis; lupus erythematosus

About this article
Title

The new European League Against Rheumatism/American College of Rheumatology 2019 classification criteria for systemic lupus erythematosus

Journal

Forum Dermatologicum

Issue

Vol 6, No 4 (2020)

Article type

Review paper

Pages

108-112

Published online

2020-12-08

Page views

2957

Article views/downloads

77

DOI

10.5603/FD.a2020.0021

Bibliographic record

Forum Dermatologicum 2020;6(4):108-112.

Keywords

diagnostics
criteria
diagnosis
lupus erythematosus

Authors

Izabela Machlarz
Adam Reich

References (7)
  1. Gergianaki I, Bortoluzzi A, Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2018; 32(2): 188–205.
  2. Fava A, Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019; 96: 1–13.
  3. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019; 78(9): 1151–1159.
  4. Hochberg M. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9): 1725–1725.
  5. Petri M, Orbai AM, Alarcón G, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64(8): 2677–2686.
  6. Johnson S, Brinks R, Costenbader K, et al. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020; 79(10): 1333–1339.
  7. Batu E, Akca UK, Kısaarslan AP, et al. The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus. J Rheumatol. 2020: jrheum.200871.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl